Telix Pharmaceuticals Limited (TLPPF)
OTCMKTS
· Delayed Price · Currency is USD
16.50
+0.30 (1.85%)
Jun 17, 2025, 2:37 PM EDT
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $5.66 billion as of June 18, 2025. Its market cap has increased by 37.50% in one year.
Market Cap
5.66B
Enterprise Value
5.58B
Revenue
484.69M
Ranking
n/a
PE Ratio
183.35
Stock Price
$16.50
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 115.28M to 5.66B, an increase of 4,813.61%. That is a compound annual growth rate of 67.03%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.59B |
| Veradigm | 764.23M |
| Elite Pharmaceuticals | 717.88M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 637.25M |
| CytoDyn | 441.29M |
| Northwest Biotherapeutics | 403.72M |
| Glass House Brands | 384.13M |